Pricing

ChromaDex Corp (CDXC)

followers ยท
Sector: INDUSTRIALS
Industry: COMMERCIAL SERVICES & SUPPLIES
SIC: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
CEO: Robert N. Fried
Employees: 120
Web site: chromadex.com
10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
310-388-6706
Stock Split History
Date Ratio
2008-03-28 11538461:1
2016-04-13 1:3
All 13F Filers Prior Change Hedge Funds 1 Prior Change
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. It researches on nicotinamide adenine dinucleotide (NAD+) and develops and commercializes proprietary-based ingredient technologies. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available